ClinicalTrials.gg
Sign In

Drug

Zirconium Zr 89 Girentuximab clinical trials

studies test it
7
open now
3
in phase 3
1
first study started
2021

Keep track of what changes. Save the Zirconium Zr 89 Girentuximab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

89Zr-girentuximab
6
89Zr-TLX250
4
89Zr-DFO-girentuximab
2
Zirconium Zr 89 Girentuximab
1

Development codes

TLX250CDx
1

Studies by the year they started

7 studies that test it; most in 2021 (3)

Studies that test Zirconium Zr 89 Girentuximab, by start year
YearStudies
20213
20231
20242
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2
Phase 2
3
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Renal Cell
4
Triple Negative Breast Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1

Who runs them

Industry 2 · Other 5

Institut Cancerologie de l'Ouest (2) · Telix Pharmaceuticals (Innovations) Pty Limited (2) · South Metropolitan Health Service (1) · Massachusetts General Hospital (1) · Jonsson Comprehensive Cancer Center (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Zirconium Zr 89 Girentuximab is read from its arms, and is right about nine times in ten.

Testing it · 7